Results for reduced intensity conditioning translation from English to Slovenian

in these studies, a total of 1574 patients received fb as a reduced intensity conditioning (ric) regimen prior to haematopoietic progenitor cell transplantation.
v teh študijah je skupno 1.574 bolnikov dobivalo fb v pripravljalni shemi ric pred transplantacijo hematopoetskih progenitorskih celic.

in adult patients who are eligible for a ‘reduced-intensity’ conditioning regimen, busilvex is given right after treatment with another medicine, fludarabine.
pri odraslih bolnikih, ki so upravičeni do pripravljalnega režima zdravljenja z zmanjšano jakostjo, se zdravilo busilvex daje neposredno po zdravljenju z drugim zdravilom, fludarabinom.

in adult patients who are eligible for a ‘reduced-intensity’ conditioning regimen, busulfan fresenius kabi is given right after treatment with another medicine, fludarabine.
pri odraslih bolnikih, ki so primerni za pripravljalni režim zdravljenja z zmanjšano jakostjo zdravila, se zdravilo busulfan fresenius kabi daje neposredno po zdravljenju z drugim zdravilom, fludarabinom.

the data from the published studies showed that busilvex in combination with fludarabine was effective as a ‘reduced-intensity’ conditioning treatment, with complete engraftment achieved in 80 to 100% of patients.
podatki iz objavljenih študij so pokazali, da je bilo zdravilo busilvex v kombinaciji s fludarabinom učinkovito kot pripravljalno zdravljenje z zmanjšano jakostjo, saj je bilo popolno prijetje doseženo pri 80 do 100 % bolnikov.

data from a recently completed prospective multicentre phase 2 study including 80 patients, aged 18 to 65 years old, diagnosed with different hematologic malignancies who underwent allo-hct with an fb (3 days of busilvex) reduced intensity conditioning regimen became available.
na voljo so podatki nedavno zaključene prospektivne multicentrične študije 2. faze pri 80 bolnikih, starih od 18 do 65 let, z različnimi hematološkimi malignimi obolenji po alo-hct s pripravljalno terapijo z zmanjšano intenzivnostjo kombinacije fb (3 dni prejemanja zdravila busilvex).

busilvex following fludarabine (fb) is indicated as conditioning treatment prior to haematopoietic progenitor cell transplantation (hpct) in adult patients who are candidates for a reduced-intensity conditioning (ric) regimen.
dajanje zdravila busilvex po fludarabinu (fb) je indicirano kot pripravljalna terapija pred transplantacijo hematopoetskih progenitorskih celic (hpct) pri odraslih bolnikih, ki so kandidati za zdravljenje z zmanjšano intenzivnostjo (ric).

since busilvex in combination with fludarabine has been used in clinical practice for many years, data from 7 studies (involving 731 patients) which looked at the effectiveness of busilvex and fludarabine as ‘reduced-intensity’ conditioning treatment were presented.
ker se zdravilo busilvex v kombinaciji s fludarabinom že več let uporablja v klinični praksi, so bili predstavljeni podatki iz sedmih študij, v katere je bilo vključenih 731 bolnikov in v katerih so proučevali učinkovitost zdravila busilvex in fludarabina kot pripravljalnega zdravljenja z zmanjšano jakostjo.